image
Repligen Corporation RGEN
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
Watchlist
$ 124.73
-12.4 %
$ 6.99 B
Market Cap
-4157.67
P/E
INCOME STATEMENT
639 M REVENUE
-20.31%
Growth Rates
1Year -20.31%
3Years 20.37%
5Years 26.91%
7Years 29.51%
10Years 25.08%
54.6 M OPERATING INCOME
-59.15%
Growth Rates
1Year -59.15%
3Years 8.66%
5Years 16.00%
7Years 19.19%
10Years 9.09%
41.6 M NET INCOME
-77.64%
Growth Rates
1Year -77.64%
3Years -11.47%
5Years 20.13%
7Years 19.89%
10Years 9.96%
EFFICIENCY
Earnings Waterfall Repligen Corporation
image
Revenue 639 M
Cost Of Revenue 355 M
Gross Profit 284 M
Operating Expenses 230 M
Operating Income 54.6 M
Other Expenses 13 M
Net Income 41.6 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Mar-2011 Mar-2010 Mar-2009 Mar-2008 Mar-2007 Mar-2006 Mar-2005 Mar-2004 Mar-2003 Mar-2002 Mar-2001 Mar-2000 Mar-1999 Mar-1998 Mar-1997 Mar-1996 Mar-1995 Mar-1994 Mar-1993 Mar-1992 Mar-1991 Mar-1990 Mar-1989 Mar-1988 Mar-1987 Mar-1986
REVENUE
Revenue 638.8 801.5 670.5 366.3 270.2 194.0 141.2 104.5 83.5 63.5 68.2 62.3 27.3 21.0 29.4 19.3 14.1 12.9 9.4 6.9 7.8 4.3 2.3 3.5 2.6 2.4 3.8 10.9 16.9 26.8 27.3 11.7 7.6 12.7 8.5 10.2 3.7 3.6
GROSS PROFIT
Cost Of Revenue 354.5 345.8 279.3 156.6 119.1 86.0 67.0 47.1 35.3 28.0 25.2 27.2 7.1 5.5 6.8 6.2 3.6 3.6 3.9 3.2 3.5 2.0 1.1 0.8 0.4 0.3 0.3 100 K (1.1) 1.5 (0.5) (0.2) (0.6) 10.5 7.6 7.2 4.4 2.6
Gross Profit 284.2 455.7 391.3 209.6 151.1 108.1 74.2 57.4 48.3 35.5 43.0 35.1 20.2 15.5 22.6 13.1 10.5 9.4 5.5 3.7 4.3 2.3 1.2 2.7 2.2 2.1 3.5 10.8 18.0 25.3 27.8 11.9 8.2 2.2 0.9 3.0 (0.7) 1.0
OPERATING INCOME
Operating Expenses 230.3 259.8 218.1 139.8 115.1 82.1 60.2 38.2 30.4 22.8 20.0 23.7 20.5 21.2 18.7 (22.8) 12.3 10.6 9.6 13.6 9.4 7.9 8.6 6.6 3.7 2.9 4.0 18.6 38.3 44.5 39.1 24.7 16.5 4.7 4.3 4.1 4.2 3.5
Selling, General and Administrative Expenses 218.1 215.8 183.9 119.6 95.6 66.3 51.5 30.9 24.7 17.2 12.7 13.2 8.0 7.1 5.9 10.2 6.4 5.4 4.6 4.7 4.2 2.5 2.5 2.5 1.6 1.3 2.4 4.9 4.7 42.1 37.4 23.6 15.6 3.9 3.7 3.6 3.6 3.0
Research and Development Expenses 42.7 43.9 34.3 20.2 19.4 15.8 8.7 7.4 5.7 5.6 7.3 10.5 12.5 14.2 12.8 7.2 5.9 5.2 5.0 6.5 5.2 5.4 5.8 3.8 1.8 1.4 1.4 12.3 31.0 0 0 0 0 0 0 0 0 0
Operating Income 54.6 133.6 133.5 42.5 14.9 26.0 14.0 16.0 13.8 10.7 22.9 11.1 (0.4) (5.8) 3.9 35.9 (1.8) (1.2) (4.2) (9.9) (5.1) (5.6) (7.3) (3.9) (1.5) (0.8) (0.5) (7.8) (20.3) (19.2) (11.3) (12.8) (8.3) (2.5) (3.4) (1.1) (4.9) (2.5)
PRE-TAX INCOME
Interest Income Expense 10.0 1.2 12.7 12.1 9.3 6.7 6.4 3.8 32 K 50 K 49.8 K 56.7 K 26.2 K 1.97 K 2.96 K 2.96 K (0.9) 0.7 (3.0) (9.6) (4.5) (4.5) (5.3) (3.8) (2.5) (0.8) (0.5) (11.5) (32.0) (19.5) (11.3) (12.8) (5.7) (2.4) (3.3) 0.3 (20.7) (1.4)
Total Other Income 9.6 (5.5) (13.7) (10.6) (9.9) (4.6) (6.8) (4.3) (0.3) 0.4 0.1 (0.1) (2.3) 5.7 0.9 1.9 39.8 0.9 1.9 1 177.8 5.4 1.1 2.1 3.5 1.9 2.0 0.3 0.5 7.8 0.8 7.9 0 7.1 5.9 2.5 3.7 1.1 3.5
Pre-Tax Income 64.1 219.1 153.5 59.2 26.2 21.4 7.2 11.7 13.4 11.1 23.0 11.3 43.5 K (4.9) 5.8 37.9 (0.9) 0.7 (3.0) (9.6) (4.5) (4.5) (5.3) (3.8) (2.5) (0.8) (0.5) (11.5) (32.0) (19.5) (11.3) (12.8) (5.7) (2.4) (3.3) 0.3 (20.7) (1.4)
NET INCOME
Tax Provision 22.6 33.2 25.3 (0.7) 4.7 4.8 (21.1) 11 K 4.1 3.0 6.9 (2.9) (0.3) (0.8) 26.7 K 0.8 0.9 (0.7) 3.0 9.6 4.5 4.5 5.3 3.8 2.5 0.8 0.5 11.5 32.0 19.5 11.3 12.8 5.7 2.4 3.3 (0.3) 20.7 1.4
Net Income 41.6 186.0 128.3 59.9 21.4 16.6 28.4 11.7 9.3 8.2 16.1 14.2 43.5 K (4.1) 5.7 37.1 (0.9) 0.7 (3.0) (9.6) (4.5) (4.5) (5.3) (3.8) (2.5) (0.8) (0.5) (11.5) (32.0) (19.5) (11.3) (12.8) (5.7) (2.4) (3.3) 0.3 (20.7) (1.4)
EPS 0.75 3.35 2.33 1.14 0.44 0.38 0.74 0.35 0.28 0.25 0.51 0.46 0.0014 0.13 0.19 1.2 0.0293 0.0231 0.0992 0.32 0.17 0.17 0.2 0.18 0.14 0.0485 0.03 0.75 2.08 1.53 0.93 1.14 0.63 0.31 0.46 0.0411 3.59 0.47